2 hrs ago | Medical News Today
New Mouse Model Helping To Keep Stem Cells Strong
Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Immune System / Vaccines ; Stem Cell Research Article Date: 24 May 2013 - 1:00 PDT When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness.
6 hrs ago | Examiner.com
Radioactive nanoparticles have been developed to target cancer cells
The fight against cancer remains aggressive from many dimensions, with radiation therapy, chemotherapy, surgery and natural interventions dealing with healthy diets and exercise being promoted.
Brittany Kipfmiller of Canton brought her support team with her to Canton's Relay for Life Saturday.
Study Finds 'Serious Problems' With 2012 Alzheimer's 'Breakthrough'
Last year's finding that the drug bexarotene reduced the buildup of Alzheimer's-causing plaques may not legitimate, a new study finds.
Otago honours leading physician-scientist Professor Helen Heslop
The University of Otago will this weekend confer the honorary degree of Doctor of Science on Professor Helen Heslop, an Otago graduate who has forged an outstanding medical and research career overseas.
Friday night, the American Legion Riders of Post 254 are holding a Full Moon Dart Run to help raise money for one of their own.
Dr. Mary Horowitz Inducted into Association of American Physicians
Mary Horowitz, MD, MS, Robert A. Uihlein, Jr. Chair in Hematologic Research, professor of medicine and chief of the division of hematology and oncology at the Medical College of Wisconsin , was inducted into the Association of American Physicians at the group's annual meeting in Chicago.
International Scientific Forum on Alcohol Research Critique 112:...
The latest critique from the ISFAR considers a study that looks at rates of death from cancer, related to alcohol consumption There have been many papers relating alcohol intake to specific types of cancer.
AN Andover man has taken on a 16-hour golf challenge at Bishopswood Golf Club to raise money for Macmillan Cancer research.
New treatments see blood cancer survival rates up
MORE than half of patients diagnosed with non-Hodgkin lymphoma are now surviving the cancer thanks to improved diagnosis and treatment, campaigners have said.
Weld DA Buck announces he is cancer-free after months of treatment
He said Monday that he will undergo three more chemotherapy treatments to ensure that the cancer is completely gone, but he's hopeful the treatments are going to be successful.
Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies
May 22, 2012 John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will bring together leading cancer experts, for presentation and discussion of the latest developments and implications of cell therapy and interventional immunology in oncology, on Friday, June 7 from 7:00am to 1:30pm. "I'm ... (more)
Cancer survivors raise awareness about blood cancers
Each year more than 12,000 Americans are diagnosed with a blood cancer, such as Leukemia and Lymphoma.
Tony Iommi of Black Sabbath Opens Up About His Battle with Cancer and ...
This is an excerpt from the July 2013 issue of Guitar World magazine. For the rest of this story, plus features on Joe Satriani, Ghost B.C., Mick Jones of Foreigner, Joe Don Rooney of Rascal Flats, plus transcriptions of "Sabbath Bloody Sabbath" and Jason Becker's "Perpetual Burn," check out the issue at the Guitar World Online Store.
Sale Creek's NHS supports students, teachers in fight with cancer
Sale Creek Middle/High School senior Niki Ables and other students are sharing in the personal fight of some of their own - the fight against cancer.
Radioactivity as a Viable Kill Mechanism in Targeted Therapies
Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction.
Radioactive nanoparticles target cancer cells
Once cancer has reached this stage, it becomes very difficult for doctors to locate and treat the numerous tumors that can develop.
The plug has been pulled on a phase III randomized, open-label trial that was evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ aggressive non-Hodgkin lymphoma who were not candidates for intensive high-dose chemotherapy.
Pfizer halts study of lymphoma drug unlikely to help survival
Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not likely to improve survival.